Skip to content

Impact of yoga on cognitive functions, quality of life and social and occupational functions in Schizophrenia

Impact of yoga on neurocognitive variables, quality of life and socio-occupational functioning in Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/06/008767
Enrollment
30
Registered
2017-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Schizophrenia

Interventions

Intervention1: AYUSH: NIL Intervention2: Yoga therapy: NIMHANS yoga module for schizophrenia will be used. A trained staff from yoga department will train patients for five session. Thereafter the pat

Sponsors

Dr Samant Darshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients meeting the diagnostic criteria for schizophrenia in DSM-5 2.CGI score of 3.Males and females between 18 and 45 years 4.Patients without significant extrapyramidal Symptoms with SAS Score of 5.Patients in whom dose or the antipsychotic has not been changed over the last 6 weeks 6.Able to read, write and speak Kannada or English 7.Patients amenable to neuro-cognitive testing 8.Patients amenable or suitable for the particular yoga/ physical exercise 9.Patient and guardian who are willing to give consent for participation in the study

Exclusion criteria

Exclusion criteria: 1.Patients with co-morbid psychiatric diagnosis 2.Patients currently using psychoactive substance other than nicotine in dependence pattern over the last three months 3.Patients not amenable to neuro-cognitive testing due to poor comprehension or attention span. 4.Patients not amenable or suitable for the particular yoga/ physical exercise due to body structure, joint pains, respiratory difficulties etc. 5. Patients with significant extrapyramidal symptoms SAS score >=4 6. Patients with any uncontrolled physical comorbidity 7. Patients not consenting for the study

Design outcomes

Primary

MeasureTime frame
Neuro-cognitive functioning, quality of life and soci-occupational functioning.Timepoint: Yoga group will receive 6 weeks of yoga therapy and will be assessed at baseline, at 3 weeks and at the end of 6 week period. wait-list group will receive yoga therapy after 6 weeks of waiting period. This group will also undergo 6 weeks of yoga therapy after the waiting period is over. They will be assessed at baseline, 3 weeks, 6 weeks (at the completion of waiting period), 9 weeks (during the yoga therapy) and 12 weeks (at the completion of yoga therapy).

Secondary

MeasureTime frame
Positive and negative symptoms of Schizophrenia Extrapyramidal symptomsTimepoint: Yoga group will receive 6 weeks of yoga therapy and will be assessed at baseline, at 3 weeks and at the end of 6 week period. wait-list group will receive yoga therapy after 6 weeks of waiting period. This group will also undergo 6 weeks of yoga therapy after the waiting period is over. They will be assessed at baseline, 3 weeks, 6 weeks (at the completion of waiting period), 9 weeks (during the yoga therapy) and 12 weeks (at the completion of yoga therapy).

Countries

India

Contacts

Public ContactDr Samant Darshi

Kasturba Medical College

psvn.sharma@manipal.edu0820-2922217

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026